Sarepta Therapeutics stock at EUR 16.77 as investor events near

Sarepta Therapeutics stock traded at EUR 16.77 on Lang & Schwarz at 13:04 CET on Saturday, October 31, 2026. The next scheduled investor event is a two-conference appearance on November 9.

Management sets November appearances

In an investor relations release published October 26, Sarepta said senior management will participate in the Wolfe Research Healthcare Conference in New York City and the Guggenheim Securities Healthcare Innovation Conference in Boston on November 9.

The Guggenheim appearance includes a 3 p.m. ET fireside chat. Sarepta said the presentation will be webcast through its investor relations website and archived there for 90 days, giving investors a scheduled opportunity to hear management discuss the company's rare-disease programs.

Upcoming milestones for investors

The conference appearances provide the next public management touchpoint after October's clinical and commercial focus. Investors will likely watch for updates on Sarepta's Duchenne muscular dystrophy franchise and its broader pipeline across muscle, central nervous system and cardiac diseases.

For the latest real-time quote of Sarepta Therapeutics stock, investors can follow the dedicated share page.

Broader US equities can be followed in the S&P 500 market coverage.

More news and analyses on Sarepta Therapeutics stock are available in the company topic section.